Oyster Point Pharma, Inc. |
Director |
Common Stock |
415K |
$4.64M |
$11.20 |
Jan 5, 2022 |
Indirect |
Tarsus Pharmaceuticals, Inc. |
Director |
Common Stock |
167K |
$4.43M |
$26.53 |
Aug 12, 2024 |
Direct |
GLAUKOS Corp |
Director |
Common Stock |
40.5K |
$3.81M |
$94.01 |
Jun 3, 2021 |
Indirect |
LENSAR, Inc. |
Director |
Common Stock |
543K |
$2.41M |
$4.43 |
May 7, 2024 |
Direct |
GLAUKOS Corp |
Director |
Common Stock |
17.8K |
$1.68M |
$94.01 |
Jun 3, 2021 |
Direct |
RxSight, Inc. |
Director |
Common Stock |
27.1K |
$1.66M |
$61.09 |
Jun 6, 2024 |
Direct |
RxSight, Inc. |
Director |
Common Stock |
21.2K |
$1.3M |
$61.09 |
Jun 6, 2024 |
Indirect |
Oyster Point Pharma, Inc. |
Director |
Common Stock |
33.5K |
$375K |
$11.20 |
Jan 5, 2022 |
By Limited Partnership |
Oyster Point Pharma, Inc. |
Director |
Common Stock |
27.9K |
$313K |
$11.20 |
Jan 5, 2022 |
By LLC |
Tarsus Pharmaceuticals, Inc. |
Director |
Common Stock |
10.4K |
$277K |
$26.53 |
Aug 12, 2024 |
By Link Family Enterprise, LP |
Oyster Point Pharma, Inc. |
Director |
Common Stock |
10.1K |
$113K |
$11.20 |
Jan 5, 2022 |
Direct |
Tarsus Pharmaceuticals, Inc. |
Director |
Stock Option (right to buy) |
5K |
$55K |
$10.99 |
Jun 13, 2024 |
Direct |
Oyster Point Pharma, Inc. |
Director |
Common Stock |
2.07K |
$23.2K |
$11.20 |
Jan 5, 2022 |
By Trust |
Tarsus Pharmaceuticals, Inc. |
Director |
Common Stock |
0 |
$0 |
$26.53 |
Aug 12, 2024 |
By Flying L Partners XI, LLC |
Tarsus Pharmaceuticals, Inc. |
Director |
Restricted Stock Units |
0 |
$0 |
$27.47 |
Jun 24, 2024 |
Direct |
LENSAR, Inc. |
Director |
Stock Option (Right to Buy) |
33.2K |
|
|
May 25, 2023 |
Direct |